Assenagon Asset Management S.A. Increases Position in Masimo Co. (NASDAQ:MASI)

Assenagon Asset Management S.A. lifted its position in shares of Masimo Co. (NASDAQ:MASI) by 916.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 216,051 shares of the medical equipment provider’s stock after purchasing an additional 194,788 shares during the period. Assenagon Asset Management S.A.’s holdings in Masimo were worth $35,713,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of MASI. NBC Securities Inc. lifted its holdings in Masimo by 47.1% during the 3rd quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 73 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in Masimo by 133.3% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 200 shares during the last quarter. GAMMA Investing LLC lifted its stake in Masimo by 136.5% during the fourth quarter. GAMMA Investing LLC now owns 466 shares of the medical equipment provider’s stock worth $77,000 after purchasing an additional 269 shares during the last quarter. Harvest Fund Management Co. Ltd acquired a new position in Masimo in the third quarter valued at approximately $118,000. Finally, Assetmark Inc. increased its stake in Masimo by 12.7% in the third quarter. Assetmark Inc. now owns 1,183 shares of the medical equipment provider’s stock valued at $158,000 after purchasing an additional 133 shares during the last quarter. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Trading Down 1.2 %

Shares of Masimo stock opened at $169.94 on Friday. The company’s fifty day moving average is $169.03 and its two-hundred day moving average is $139.75. Masimo Co. has a 1 year low of $101.61 and a 1 year high of $180.97. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. The company has a market capitalization of $9.10 billion, a P/E ratio of 117.20 and a beta of 1.01.

Masimo (NASDAQ:MASI) last released its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.84 by $0.14. The firm had revenue of $504.60 million for the quarter, compared to analyst estimates of $502.87 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The business’s revenue was up 5.4% on a year-over-year basis. During the same quarter last year, the company posted $0.63 earnings per share. Analysts forecast that Masimo Co. will post 4.03 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on MASI. BTIG Research boosted their price objective on shares of Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research report on Thursday. Raymond James raised their price objective on Masimo from $170.00 to $194.00 and gave the stock an “outperform” rating in a report on Friday, December 27th. Wells Fargo & Company boosted their target price on Masimo from $171.00 to $193.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. Finally, Piper Sandler upped their target price on Masimo from $180.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, December 18th. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, Masimo has an average rating of “Moderate Buy” and an average target price of $179.67.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.